Combination PPAR𝛾 and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2

Table 2

Microarray Analysis of A375(DRO) cells after TZD/rexinoid combination treatment—2-fold down regulated genes.

Gene Symbol	fold change	GenBank ID
ABAT	$-17.5$	NM_000663
TSFM	$-10.4$	NM_005726
XRCC4	$-9.0$	NM_003401
NUDT1	$-8.9$	NM_002452
ZIC1	$-8.3$	NM_003412
BARD1	$-8.2$	NM_000465
CDC25A	$-8.2$	NM_001789
MAP9	$-8.1$	NM_001039580
QPCT	$-7.9$	NM_012413
C12orf52	$-7.8$	NM_032848
PTCD2	$-7.3$	NM_024754
TLE1	$-6.8$	NM_005077
MYO6	$-6.4$	NM_004999
WDR59	$-6.0$	NM_030581
RARS	$-5.6$	NM_002887
BIN1	$-5.2$	NM_004305
WBP1	$-5.2$	NM_012477
CSGALNACT1	$-5.1$	NM_018371
CAMTA1	$-5.1$	NM_015215
TRIM23	$-5.1$	NM_001656